Executive Report-4

National Alliance of Methadone Advocates
The President’s Office
Joycelyn Woods

Executive Report



DRAFT New York State Regulations, Page 4 of 5

Similar Posts

  • Policy Statements

    Admin 11/02/2021

    Policy Statement 1 Methadone Medical Maintenance April 1994 Download File  (pdf format) Policy Statement 2 The Policy of Blind Dosing and Patient Dignity April 18, 1994 Download File (pdf format) Policy Statement 3 Discharge From Treatment for Drug Use May 1994 Download File (pdf format) Policy Statement 4 Patient vs Client May 1994 Download File (pdf format) Policy…

  • References

    Admin 09/12/2022

    Batki, S.L.  Treatment of intravenous drug users with AIDS:  The role of methadone maintenance.  Journal of Psychoactive Drugs 1988 20: 213-216. Legal Action Center. Beazer vs New York City Transit Authority: A Landmark Decision on Methadone Maintenance [Report].  New York: National Institute on Drug Abuse, 1975.   Des Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et…

  • The National Methadone Conference-4

    Admin 01/16/2022

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Hot Topic: Administrative Detox Facilitator: Joe Neuberger Delaware NAMA Bitch and Gripe.Com Administrative Detox is our subject. It is a policy whereby methadone patients in treatment are banished from their programs for the umbrella term of “non-compliance.” Now we’re not talking…

  • Chapters and Affiliates

    Admin 04/20/2022

    Websites, Message Boards, Lists, Discussion Groups, Zines & Newsletters   National Alliance of Methadone Advocates Discussion & Message Board We Speak Methadone National Alliance of Methadone Advocates eAlert Subscribe Here via Email National Alliance of Methadone Advocates NAMA Advocate https://www.methadone.org/nama_advocate.htm National Alliance of Methadone Advocates Archives of The Ombudsman https://www.methadone.org/pubs.html BAMA~NAMA BAMA-MISS NAMA & Dolophinia…

  • |

    FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction Drug

    Admin 03/17/2023

    FDA Talk Paper April 20, 2001 T01-15 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The FDA is strengthening warnings to physicians about serious cardiac adverse events associated with Orlaam (levomethadyl acetate HC), a drug for opiate addiction treatment. FDA has changed the Orlaam labeling to increase the strength of the warnings and to…